Loading clinical trials...
Loading clinical trials...
A Prospective Randomized Trial Comparing the Response of HIV Kaposi's Sarcoma (KS) to HAART Versus the Combination of HAART and Chemotherapy (CXT)
Conditions
Interventions
Generic HAART Triomune : d4T, 3TC, NVP
Generic HAART Triomune : d4T, 3TC, NVP and chemotherapy ABV
Locations
1
South Africa
Department of Dermatology, King Edward VIII Hospital
Durban, KwaZulu-Natal, South Africa
Start Date
January 1, 2003
Primary Completion Date
February 1, 2009
Completion Date
March 1, 2009
Last Updated
July 21, 2010
NCT07071623
NCT01875588
NCT04929028
NCT03087253
NCT07199335
NCT05419024
Lead Sponsor
University of KwaZulu
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions